𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Maternal influenza during pregnancy and risk of congenital abnormalities in offspring

✍ Scribed by NÁndor ács; Ferenc Bánhidy; Erzsébet Puhó; Andrew E. Czeizel


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
114 KB
Volume
73
Category
Article
ISSN
1542-0752

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

The teratogenic effect of influenza viruses is currently being debated, and we examined the large population‐based data set of the Hungarian Case‐Control Surveillance of Congenital Abnormalities (HCCSCA) to study the possible association between maternal influenza and various congenital abnormalities (CAs).

METHODS

The 1980–1996 HCCSCA includes 22,843 newborns or fetuses with CAs, and 38,151 matched controls (newborn infants without any abnormalities).

RESULTS

In the case group, 1328 (5.8%) mothers had influenza at some time during their pregnancies compared to 1838 (4.8%) mothers in the control group (adjusted prevalence odds ratios [PORs], 1.3; 95% confidence interval [CI], 1.2–1.4). In the calculation of the adjusted PORs, the use of antifever drugs and maternal employment status were considered. When cases and their matched controls were compared, there was a higher prevalence of maternal influenza during the second and/or third month of pregnancy for the group of newborns with cleft lip ± palate (adjusted POR, 3.2; 95% CI, 2.0–5.3), neural‐tube defects (adjusted POR, 1.9; 95% CI, 1.1–3.3), and cardiovascular malformations (adjusted POR, 1.7; 95% CI, 1.3–2.3). However, a direct teratogenic effect from influenza viruses appears to be unlikely, and we suggest that the higher prevalence of the CAs indicated above can be explained mainly by fever, because this risk was reduced by the use of antifever drugs. Periconceptional folic acid supplementation also showed some preventive effect for these CAs.

CONCLUSIONS

The indirect teratogenic effect of maternal influenza during pregnancy may be restricted by appropriate medical treatment (e.g., antifever drugs) and periconceptional folic acid supplementation. Birth Defects Research (Part A), 2005. © 2005 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Maternal fever during early pregnancy an
✍ S. Shahrukh Hashmi; M. Shayne Gallaway; D. Kim Waller; Peter H. Langlois; Jacque 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract An increased risk of birth defects after hyperthermic exposures has been confirmed in animal studies, but population studies have yielded inconsistent results. Oral clefts are a common birth defect and have been associated with these exposures in some of these studies. In this study, da

Beta2-agonists use during pregnancy and
✍ Sherif Eltonsy; Amélie Forget; Lucie Blais 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

## Abstract ## BACKGROUND Treatment of asthma symptoms during pregnancy is crucial for maternal and fetal health. Short‐acting beta~2~‐agonists (SABA) are frequently used as rescue medications and long‐acting beta~2~‐agonists (LABA) are used as add‐on controller therapy for asthma during pregnancy

Maternal alcohol drinking pattern during
✍ Katrine Strandberg-Larsen; Lise Skrubbeltrang Skov-Ettrup; Morten Grønbæk; Anne- 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Background: This cohort study examines the possible association between maternal alcohol intake, including binge drinking, during pregnancy, and the subsequent risk of having a child with an isolated congenital heart defect and, more specifically, with the isolated form of ventricular septal def